Voriconazole Tablets (Amerisource) – Supplier Notification (2025)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11.
Brand
Amerisource Health Services LLC
Lot Codes / Batch Numbers
Lot # 1014138, Exp 04/30/2025
Products Sold
Lot # 1014138, Exp 04/30/2025
Amerisource Health Services LLC is recalling Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered dos due to cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026